Rare Disease Biotech Offers Access Ahead of Key Milestone
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Donald Trump Calls For Soros To Be Imprisoned: 'He's A Bad Guy'
President Trump has advocated for the imprisonment of billionaire Democratic donor George Soros.
Tucker Carlson Asks OpenAI CEO Sam Altman If He Ordered Employee's Murder
During an interview with OpenAI CEO Sam Altman, Tucker Carlson suggested Altman may have played a role in the death of former employee Suchir Balaji.
Wall Street Legend Issues Chilling New Warning: "I've Never Seen Anything as Dangerous as This" - Ad
The man who predicted the 2008 crash and 2020 says today's soaring markets are NOT a bubble - they're something far stranger and more dangerous. He says it's about to change everything you know about money.
South Korea Pours More Cold Water On Trump's $350 Billion Deal, Seoul's Top Security Advisor Says Given US Track Record Currency Swap 'Won't Be Easy'
South Korea's national security chief, Wi Sung-lac, struck a cautious note on Monday, expressing concerns that securing a bilateral currency swap agreement with the United States would be hard to come by.
5 Stocks Investors Couldn't Stop Talking About This Week— Here's How They Fared: ORCL, OPEN, NBIS, UNH, AAPL
Retail investors buzzed about 5 stocks this week, from Sept. 8 to 12, on X and Reddit's r/WallStreetBets: ORCL, OPEN, NBIS, UNH, AAPL.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Plunging Mortgage Rates Could Light Up These 9 Stocks
Mortgage rates are dropping at their fastest pace in nearly a year. Homebuilders, loan servicers and retailers could benefit.
FTC sues Ticketmaster, saying it forces fans to pay more for concerts and events
The Federal Trade Commission and a bipartisan group of state attorneys general sued Ticketmaster and its parent company Thursday, saying they are forcing consumers to pay more to see live events through a variety of illegal tactics.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Ford is moving its world headquarters for the first time in 7 decades to a new campus 3 miles away
DEARBORN, Mich. (AP) — Ford Motor Co. is taking a drive down the road in a couple of months.
McDonald's plans $200 million investment to promote regenerative practices on US cattle ranches
McDonald’s said Monday it plans to invest $200 million over the next seven years to promote on cattle ranches.
Digital Gold. Digital Oil. Digital Infrastructure. - Ad
Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.
Cracker Barrel expects weaker sales and restaurant traffic after logo controversy
Cracker Barrel said Wednesday it expects lower sales and weaker customer traffic in the coming year as the continues to play out.
Elon Musk's Two-Word Response, Trump Administration's Patent Share, Palantir CEO's China Warning And More: This Week In Politics
Elon Musk clashed with the U.S. Department of Energy over its remarks on renewable energy, emphasizing the need for large-scale batteries.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Donald Trump Lauds Economic Success, Yet Public Sentiment Tells A Different Story
The U.S. economy, despite being hailed as robust by President Trump, has failed to win over the American voters.
Trump files $15 billion defamation lawsuit against The New York Times
NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Howard Lutnick's Push For Government Ownership In Intel, Defense Giants Sparks Wall Street Concern
Commerce Secretary Howard Lutnick is launching an "investment accelerator" to secure government stakes in major companies.
FanDuel agrees to pay Jaguars roughly $5M to offset losses from ex-employee's theft, AP source says
JACKSONVILLE, Fla. (AP) — FanDuel has agreed to pay the Jacksonville Jaguars roughly $5 million to help offset the nearly $20 million that a and deposited at the sportsbook, a person familiar with discussions said Friday.
The First Public Cash-Flowing Digital Treasury - Ad
Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.
Bill Holdings Shares Soar On Elliott Management Stake: Is An Activist Battle Brewing?
Bill Holdings stock is trading higher with a new activist investor circling the company. Shareholders could find out if two activists are better than one.
Charlie Kirk Killed In Utah Shooting, Drawing Bipartisan Condemnation
House Speaker Johnson condemned the act: "This is not who we are." As of Sept. 9, there have been 298 mass shootings in the U.S. for 2025.
Why Trump's "Smart Dollar" Could Rewrite the Rules - Ad
Congress just approved President Trump's latest plans for the dollar - and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.
Bitcoin Jumps On Cooler Inflation; Ethereum, XRP, Dogecoin Gain — Analysts See BTC Trading In This Range Until The Fed Meet
Leading cryptocurrencies rallied on Wednesday as U.S. producer inflation unexpectedly cooled, boosting the chances of interest rate cuts.
Lennar Shares Are Trading Lower Friday: What's Going On?
Lennar shares are trading lower Friday after the company reported worse-than-expected third quarter financial results on Thursday after the market closed.
The Next Evolution in Public Treasuries - Ad
MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.
Asian shares are mostly up after US stocks inch to more records as inflation slows and Oracle soars
MANILA, Philippines (AP) — Asian shares were mostly higher Thursday, buoyed by gains of tech-related stocks after Wall Street inched to more records following a surprisingly encouraging report on inflation and a stunning forecast for growth from Oracle because of the boom.
China launches probes targeting US semiconductors ahead of Madrid trade talks
TAIPEI, Taiwan (AP) — China launched two probes targeting the U.S. semiconductor sector Saturday ahead of this week on trade, national security and the ownership of social media platform TikTok.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Blue Chip Stocks With Fat Dividends: Smart Buy Or Value Trap?
Several top blue-chip stocks sport big dividend yields, but weak cash flow and sector headwinds raise questions of value trap versus smart buy.
Lutnick Hints At Fannie Mae, Freddie Mac IPO In 2025 To Show The 'Mark To Market' Worth To American Taxpayers—'Largest IPO In History'
Commerce Secretary Howard Lutnick suggested that the U.S. government is considering a public offering for Fannie Mae and Freddie Mac, a move that could be implemented this year.
Wall Street Legend Issues Chilling New Warning: "I've Never Seen Anything as Dangerous as This" - Ad
The man who predicted the 2008 crash and 2020 says today's soaring markets are NOT a bubble - they're something far stranger and more dangerous. He says it's about to change everything you know about money.
FBI Finds John Bolton's Personal Email Was Breached By Foreign Entity
The personal email account of former National Security Adviser John Bolton was reportedly compromised by a foreign entity.
Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report
Corteva is exploring a breakup that would separate its seed and pesticide businesses. The move could reshape agriculture amid falling crop prices and rising costs.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Carney Cuts The Red Tape, Unveils Over $43 Billion In Flagship Projects
PM Mark Carney announces first projects to be reviewed by Canada's new Major Projects Office, aiming to cut red tape and attract investments.
Scott Bessent Meets BlackRock's Rick Rieder As Trump Eyes Fed Chair Replacement For Jerome Powell: Report
Scott Bessent is interviewing candidates to replace Jerome Powell as Federal Reserve Chair by May 2026, with BlackRock's Rick Rieder among those being considered.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.